July 10, 1993 |
The U.S. Senate has proposed a 25% cut in Medicare reimbursement payments for artificial lenses used in cataract surgery, a move that could cost hundreds of jobs in California, a Washington industry group warned on Friday. The Health Industry Manufacturers Assn. said that almost all the medical device firms that make so-called intraocular lenses are in Southern California. Allergan Inc., based in Irvine, is the largest manufacturer of such lenses.